Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin J Prestwich

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 31, 2011
Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomasRobin J Prestwich, Didem Çolpan Öksüz, Karen Dyker, et al.
Clinical Medicine. Oncology|September 6, 2011
Oncolytic viruses: do they have a role in anti-cancer therapy?Robin J Prestwich, Fiona Errington, Kevin J Harrington, et al.
Expert Review of Anticancer Therapy|October 18, 2008
Oncolytic viruses: a novel form of immunotherapyRobin J Prestwich, Kevin J Harrington, Hardev S Pandha, et al.
Human Gene Therapy|July 28, 2009
The case of oncolytic viruses versus the immune system: waiting on the judgment of SolomonRobin J Prestwich, Fiona Errington, Rosa M Diaz, et al.
Radiation Oncology (London, England)|May 26, 2011
Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapyDidem C Oksuz, Robin J Prestwich, Brendan Carey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirusRobin J Prestwich, Fiona Errington, Lynette P Steele, et al.
BJU International|November 15, 2008
The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinomaRobin J Prestwich, Karen J Scott, Joanne Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replicationRobin J Prestwich, Elizabeth J Ilett, Fiona Errington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Tumor infection by oncolytic reovirus primes adaptive antitumor immunityRobin J Prestwich, Fiona Errington, Elizabeth J Ilett, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Radiation Oncology, Biology, Physics|May 31, 2011
Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomasRobin J Prestwich, Didem Çolpan Öksüz, Karen Dyker, et al.
Clinical Medicine. Oncology|September 6, 2011
Oncolytic viruses: do they have a role in anti-cancer therapy?Robin J Prestwich, Fiona Errington, Kevin J Harrington, et al.
Expert Review of Anticancer Therapy|October 18, 2008
Oncolytic viruses: a novel form of immunotherapyRobin J Prestwich, Kevin J Harrington, Hardev S Pandha, et al.
Human Gene Therapy|July 28, 2009
The case of oncolytic viruses versus the immune system: waiting on the judgment of SolomonRobin J Prestwich, Fiona Errington, Rosa M Diaz, et al.
Radiation Oncology (London, England)|May 26, 2011
Recurrence patterns of locally advanced head and neck squamous cell carcinoma after 3D conformal (chemo)-radiotherapyDidem C Oksuz, Robin J Prestwich, Brendan Carey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2009
Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell infection by oncolytic reovirusRobin J Prestwich, Fiona Errington, Lynette P Steele, et al.
BJU International|November 15, 2008
The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinomaRobin J Prestwich, Karen J Scott, Joanne Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replicationRobin J Prestwich, Elizabeth J Ilett, Fiona Errington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Tumor infection by oncolytic reovirus primes adaptive antitumor immunityRobin J Prestwich, Fiona Errington, Elizabeth J Ilett, et al.
Pageof 1